HCA HCA Healthcare, Inc. Common Stock

NYSE · Health Care · عرض على SEC EDGAR ↗
$417,32
السعر · أغسطس 18, 2026
البيانات الأساسية اعتبارًا من يوليو 28, 2026

حول HCA Healthcare, Inc. Common Stock نظرة عامة على الشركة من ويكيبيديا

HCA Healthcare, Inc. is an American global for-profit operator of health care facilities that was founded in 1968. It is based in Nashville, Tennessee, and, as of May 2020, owned and operated 186 hospitals and approximately 2,400 sites of care, including surgery centers, freestanding emergency rooms, urgent care centers and physician clinics in 20 states and the United Kingdom. As of 2024, HCA Healthcare is ranked #61 on the Fortune 500 rankings of the largest United States corporations by total revenue. In the 1990s, the company engaged in illegal accounting and other crimes that resulted in the payment of more than $2 billion in federal fines and other penalties, and the dismissal of the CEO Rick Scott by the board of directors.

اقرأ المزيد

HCA Healthcare, Inc. (historically known as Hospital Corporation of America) is an American global for-profit operator of health care facilities that was founded in 1968. It is based in Nashville, Tennessee, and, as of May 2020, owned and operated 186 hospitals and approximately 2,400 sites of care, including surgery centers, freestanding emergency rooms, urgent care centers and physician clinics in 20 states and the United Kingdom. As of 2024, HCA Healthcare is ranked #61 on the Fortune 500 rankings of the largest United States corporations by total revenue. In the 1990s, the company engaged in illegal accounting and other crimes that resulted in the payment of more than $2 billion in federal fines and other penalties, and the dismissal of the CEO Rick Scott by the board of directors.

History

Early years

The Hospital Corporation of America (HCA) was founded in 1968 in Nashville, Tennessee, by Thomas F. Frist Sr., Thomas F. Frist Jr. and Jack C. Massey. The founders envisioned a company that would bring together hospitals to deliver patient-focused care while using the combined resources of the organization to strengthen hospitals and improve the practice of medicine. The company began with Nashville's Park View Hospital, which the elder Frist had founded in 1960 with other doctors and where he was serving as chief executive.

The company included 11 hospitals when it filed its initial public offering on the New York Stock Exchange (NYSE) in 1969 and had 26 hospitals and 3,000 beds by the end of the year.

Growth and merger

The 1970s were characterized by rapid growth in the industry and for HCA Healthcare. In the early 1980s, the focus shifted to consolidation with HCA Healthcare acquiring General Care Corporation, General Health Services, Hospital Affiliates International and Health Care Corporation. By the end of 1981, the company operated 349 hospitals with more than 49,000 beds. Operating revenues had grown to $2.4 billion.

In 1987, HCA Healthcare, which had grown to operate 463 hospitals (255 owned and 208 managed), spun off HealthTrust, a privately owned, 104-hospital company. Believing its stock was undervalued, the company completed a $5.1 billion leveraged management buyout led by chairman Thomas F. Frist Jr. in 1988. HCA Healthcare re-emerged as a public company in 1992.

In February 1994, HCA Healthcare merged with Louisville, Kentucky-based Columbia Hospital Corporation, which earlier had acquired 73 hospitals of Galen Health Care from Humana,

to form Columbia/HCA Healthcare Corporation. Related names of note include HCA International and Health Corporation of America.

Columbia Hospital Corporation

In 1988, Rick Scott and Richard Rainwater each put up $125,000 in working capital in their new company, Columbia Hospital Corporation; they borrowed the remaining money needed to purchase two struggling hospitals in El Paso for $60 million. Then they acquired a neighboring hospital and shut it down. Within a year, the remaining two were doing much better. By the end of 1989, Columbia Hospital Corporation owned four hospitals with a total of 833 beds.

In 1992, Columbia made a stock purchase of Basic American Medical, which owned eight hospitals, primarily in southwestern Florida. In September 1993, Columbia did another stock purchase, worth $3.4 billion, of Galen Healthcare, which had been spun off by Humana Inc. several months earlier. At the time, Galen had approximately 90 hospitals. After the purchase, Galen stockholders had 82% of the stock in the combined company, with Scott still running the company.

Recent history

On November 17, 2006, HCA became a private company for the third time when it completed a merger in which the company was acquired by a private investor group including affiliates of Kohlberg Kravis Roberts and Bain Capital, together with Merrill Lynch and HCA Healthcare founder Thomas F. Frist Jr. The total transaction was valued at approximately $33 billion, making it the largest leveraged buyout in history at the time, eclipsing the 1989 buyout of RJR Nabisco.

In May 2010, HCA announced that the corporation would once again go public with an expected $4.6-billion IPO as HCA Holdings, Inc. In March 2011, HCA sold 126.2 million shares for $30 each, raising about $3.79 billion, at that time, the largest private-equity backed IPO in U.S. history. In May 2017, the corporation was renamed HCA Healthcare.

In December 2018, a historical marker was installed in the parking lot of HCA's Sarah Cannon Cancer Center in Nashville, formerly the location of HCA's first hospital, Park View Hospital.

In 2018, the company was ranked No. 67 in the 2019 Fortune 500 list of the largest United States corporations by total revenue.

In May 2021, the company finalized a deal with Google to develop healthcare algorithms using patient records. In August 2021, HCA announced a deal with venture capital firm General Catalyst to develop digital solutions to streamline workflows and improve patient care; as part of the deal, HCA sold its healthcare app development firm PatientKeeper to General Catalyst's portfolio company Commure.

In April 2022, HCA Healthcare announced a $1.5 million partnership with Florida International University's Nicole Wertheim college of Nursing and Health Sciences, to expand its facilities to address the national nursing shortage.

In October 2022, LCMC Health in partnership with Tulane University announced that it would acquire Tulane Medical Center, Lakeview Regional Medical Center, and Tulane Lakeside Hospital from HCA for $150 million pending regulatory approval.

In March 2024, it was announced HCA had completed the sale of West Hills Hospital and Medical Center and related assets in Los Angeles, California to UCLA Health, for an undisclosed amount.

Facilities

United States

As of 2024, HCA has 186 hospitals. They also report operating more than 2,400 additional sites of care, including surgery centers, freestanding ERs, urgent care centers, and physician clinics located in 20 U.S. states and in the United Kingdom. A significant portion of those hospitals are situated in Florida and Texas. As of 2022, HCA had 47 hospitals and 31 surgery centers in Florida, and 45 hospitals and 632 affiliated sites of care in Texas. In 2021, it announced plans to build 3 new hospitals in Florida. In 2022, The Dallas Morning News reported that HCA will build 5 new hospitals in Texas. They also have a strong presence in Tennessee, where it began. HCA had 13 hospitals there as of 2019.

Between 2003 and 2017, HCA did not enter any new markets. However, in July 2007, HCA sold its hospitals in Switzerland.

In 2017, HCA acquired the Memorial University Medical Center in Savannah, Georgia. That same year, they acquired three Houston, Texas, hospitals from Tenet Healthcare.

In 2019 they purchased Mission Health System which operates hospitals in North Carolina.

In January 2020, HCA Healthcare acquired Valify, a healthcare cost-management company. In May 2020, HCA acquired 49-bed Shands Starke (Fla.) Regional Medical Center and 25-bed Shands Live Oak (Fla.) Regional Medical Center from CHS. HCA is operating the two facilities as off-campus emergency departments of Lake City (Fla.) Medical Center and North Florida Regional Medical Center in Gainesville. Later that year, it signed an agreement to sell Garden Park Medical Center to Singing River Health System.

In 2021, HCA sold Redmond Regional Medical Center to AdventHealth for $635M, and four other Georgia hospitals to Piedmont Healthcare for $950 million. They also announced the acquisition of Meadows Regional Medical Center.

United Kingdom

HCA International, the UK arm of Hospital Corporation of America, "caters for around half of all private patients in London." The main hospital sites within the United Kingdom it operates include:

It opened urgent care walk-in centres at London Bridge Hospital and the Portland Hospital in March 2018. It claims that patients, on average, wait just seven minutes to see a nurse and 17 minutes to see a doctor. In February 2022, outsourced cleaning staff at London Bridge Hospital reported a lack of PPE, no access to sick pay, a lack of training and no prior warning about which rooms may be contaminated with the virus through the COVID-19 pandemic.

The Princess Grace Hospital specializes in breast cancer and surgery, aided by Kefah Mokbel and Nick Perry who, in 2005, founded The London Breast Institute.

The company opened The Harborne Hospital, a newly built private hospital located close to the Queen Elizabeth Hospital, Birmingham, in February 2024.

Significant areas of operation

Medical education

In recent years, HCA Healthcare has become a significant provider of clinical and medical education. It is the largest sponsor of graduate medical education programs in the U.S., with 56 teaching hospitals in 14 states, primarily in regions with a deficit of physician training programs. The company includes Research College of Nursing and Mercy School of Nursing, and has several advanced nursing simulation training centers. In early 2020, it completed the purchase of a majority stake in Galen College of Nursing, which operates 21 campuses in 12 states, offering Bachelor of Science and Associate of Science nursing degrees.

Controversies

Medicare billing practices lawsuit

In 1993, lawsuits were filed against HCA by former employees who alleged that the company had engaged in questionable Medicare billing practices. In 1997, with a federal investigation by the FBI, the IRS and the Department of Health and Human Services in its early stages, the Columbia/HCA board of directors forced Rick Scott to resign as chairman and CEO amid growing evidence that the company "had kept two sets of books, one to show the government and one with actual expenses listed." Thomas Frist, a co-founder of HCA and brother of U.S. Senator Bill Frist, returned to the company as CEO in 1997 and called on longtime friend and colleague Jack O. Bovender Jr. to help him turn the company around.

The federal probe culminated in 2003 with "the government receiving a total of over $2 billion in criminal fines and civil penalties for systematically defrauding federal health care programs." Columbia/HCA pleaded guilty to 14 felonies and admitted to systematically overcharging the government. The federal probe has been referred to as the longest and costliest investigation for health-care fraud in U.S. history.

2005 insider trading suit

In July 2005, U.S. Senator Bill Frist sold all of his HCA shares, which were held in a blind trust, two weeks before disappointing earnings sent the stock on a 9-point plunge. At the time, Frist was considering a run for president and said that he had sold his shares to avoid the appearance of a conflict of interest. When the company disclosed that other executives had also sold their shares during that same time, shareholders alleged that the company had made false claims about its profits to drive up the price, which then fell when the company reported disappointing financial results. Eleven of HCA's senior officers were sued for accounting fraud and insider trading. HCA settled the lawsuit in August 2007, agreeing to pay $20 million to the shareholders but admitting no wrongdoing, and no charges were brought.

COVID-19 PPE

During the COVID-19 pandemic in the United States, HCA hospital nurses and other workers spoke out about the lack of PPE. In April 2020, there was an outcry against HCA following the deaths of two nurses Celia Yap-Banago and Rosa Luna who worked at HCA hospitals in Kansas City and California and had contracted coronavirus, despite the alarm having been raised about the lack of PPE at work.

Mission Hospital Acquisition Complaints

On December 14, 2023, the North Carolina Attorney General sued HCA for violating the terms of an agreement that allowed HCA to purchase Mission Health.

On February 13, 2024, HCA Healthcare denied the allegations and asked a judge to dismiss the lawsuit by the Attorney General, and in return the hospital network filed a counterclaim against the Attorney General.

المصدر: ويكيبيديا (الإنجليزية), CC BY-SA 4.0 · عرض على ويكيبيديا ↗

Wikidata ↗

HCA لقطة سريعة للسهم السعر، القيمة السوقية، مكرر الربحية (P/E)، ربحية السهم (EPS)، العائد على حقوق الملكية (ROE)، نسبة الدين إلى حقوق الملكية، نطاق 52 أسبوعًا

السعر
$417.32
القيمة السوقية
$93.73B
P/E (TTM)
14.7
ربح السهم (آخر 12 شهرًا)
$28.33
الإيرادات (آخر 12 شهرًا)
$75.60B
عائد التوزيعات
0.73%
ROE
-159.1%
D/E الدين/حقوق الملكية
-6.9
نطاق 52 أسبوعًا
$354 – $557

HCA مخطط سعر السهم OHLCV يومي مع مؤشرات فنية — تحريك وتكبير وتخصيص عرضك

أداء 10 سنوات اتجاهات الإيرادات وصافي الدخل والهوامش وربحية السهم

الإيرادات وصافي الدخل $75.60B
10-point trend, +82.2%
2016-12-31 2025-12-31
ربح السهم $28.33
10-point trend, +288.1%
2016-12-31 2025-12-31
التدفق النقدي الحر $7.69B
10-point trend, +165.9%
2016-12-31 2025-12-31
الهوامش 9.0%

التقييم نسب مكرر الربحية (P/E)، مكرر المبيعات (P/S)، مكرر القيمة الدفترية (P/B)، EV/EBITDA — هل السهم مرتفع السعر أم رخيص؟

المقياس
اتجاه 5 سنوات
HCA
متوسط الأقران
P/E (TTM)
5-point trend, +35.7%
14.7
20.3
P/S (TTM) (السعر / المبيعات (آخر 12 شهرًا))
5-point trend, +3.8%
1.2
1.1
P/B (السعر / القيمة الدفترية)
5-point trend, +79.3%
-15.6
4.5
EV / EBITDA
5-point trend, +5.5%
38.1
Price / FCF (السعر / التدفق النقدي الحر)
5-point trend, -6.5%
12.2

الربحية هامش الربح الإجمالي والتشغيلي والصافي؛ العائد على حقوق الملكية (ROE)، العائد على الأصول (ROA)، العائد على رأس المال المستثمر (ROIC)

المقياس
اتجاه 5 سنوات
HCA
متوسط الأقران
Net Profit Margin (هامش صافي الربح)
5-point trend, -24.2%
9.0%
7.4%
ROA (العائد على الأصول)
5-point trend, -20.3%
11.3%
6.6%
ROE
5-point trend, +95.9%
-159.1%
23.2%

الصحة المالية الديون، السيولة، الملاءة المالية — قوة الميزانية العمومية

المقياس
اتجاه 5 سنوات
HCA
متوسط الأقران
Debt / Equity (الدين / حقوق الملكية)
5-point trend, +81.4%
-6.9
Current Ratio (النسبة الحالية)
5-point trend, -31.7%
1.0
1.2
Quick Ratio (النسبة السريعة)
5-point trend, -26.9%
0.7

النمو نمو الإيرادات وربحية السهم وصافي الدخل: مقارنة بالعام السابق (YoY)، متوسط النمو السنوي المركب لـ 3 سنوات (3Y CAGR)، متوسط النمو السنوي المركب لـ 5 سنوات (5Y CAGR)

المقياس
اتجاه 5 سنوات
HCA
متوسط الأقران
Revenue YoY (الإيرادات مقارنة بالعام السابق)
5-point trend, +28.7%
7.1%
Revenue CAGR 3Y (معدل نمو الإيرادات السنوي المركب لـ 3 سنوات)
5-point trend, +28.7%
7.9%
Revenue CAGR 5Y (معدل نمو الإيرادات السنوي المركب لـ 5 سنوات)
5-point trend, +28.7%
8.0%
EPS YoY (ربحية السهم على أساس سنوي)
5-point trend, +33.9%
28.8%
Net Income YoY (صافي الدخل مقارنة بالعام السابق)
5-point trend, -2.5%
17.8%

مقاييس للسهم ربحية السهم (EPS)، القيمة الدفترية للسهم، التدفق النقدي للسهم، توزيعات الأرباح للسهم

المقياس
اتجاه 5 سنوات
HCA
متوسط الأقران
EPS (Diluted) (ربحية السهم (مخففة))
5-point trend, +33.9%
$28.33

كفاءة رأس المال معدل دوران الأصول، معدل دوران المخزون، معدل دوران المستحقات

المقياس
اتجاه 5 سنوات
HCA
متوسط الأقران
Payout Ratio (نسبة التوزيع)
5-point trend, +11.6%
10.0%

التوزيعات العائد، نسبة التوزيع، تاريخ توزيع الأرباح، معدل النمو السنوي المركب لمدة 5 سنوات

عائد الأرباح
0.73%
نسبة التوزيع
10.0%
5Y Div CAGR
تاريخ الاستحقاقالمبلغ
16 يونيو، 2026$0,7800
17 مارس، 2026$0,7800
15 ديسمبر، 2025$0,7200
16 سبتمبر، 2025$0,7200
16 يونيو، 2025$0,7200
17 مارس، 2025$0,7200
13 ديسمبر، 2024$0,6600
16 سبتمبر، 2024$0,6600
14 يونيو، 2024$0,6600
14 مارس، 2024$0,6600
13 ديسمبر، 2023$0,6000
14 سبتمبر، 2023$0,6000
15 يونيو، 2023$0,6000
16 مارس، 2023$0,6000
13 ديسمبر، 2022$0,5600
15 سبتمبر، 2022$0,5600
15 يونيو، 2022$0,5600
16 مارس، 2022$0,5600
13 ديسمبر، 2021$0,4800
15 سبتمبر، 2021$0,4800

HCA توافق الآراء التحليلي آراء المحللين الصعودية والهبوطية، السعر المستهدف لمدة 12 شهرًا، الصعود

شراء 30 محللين
  • شراء قوي 6 20,0%
  • شراء 11 36,7%
  • احتفاظ 12 40,0%
  • بيع 1 3,3%
  • بيع قوي 0 0,0%

السعر المستهدف لمدة 12 شهرًا

21 محللين · 2026-08-17
السعر المستهدف الوسيط $450.00 +7,8%
السعر المستهدف المتوسط $454.57 +8,9%

سجل الأرباح ربحية السهم الفعلية مقابل التقديرات، نسبة المفاجأة %، معدل التجاوز، تاريخ الأرباح التالي

متوسط المفاجأة
0.49%
الفترة EPS Actual EPS المتوقع المفاجأة
30 يونيو، 2026 $7.62 $7.54 0.08%
31 مارس، 2026 $7.15 $7.21 -0.06%
31 ديسمبر، 2025 $8.14 $7.53 0.61%
30 سبتمبر، 2025 $6.96 $5.77 1.2%
30 يونيو، 2025 $6.83 $6.31 0.52%
31 مارس، 2025 $6.45 $5.84 0.61%

مقارنة الأقران (الصناعة الفرعية GICS) المقاييس الرئيسية مقابل أقران القطاع

الرمز القيمة السوقية P/E الإيرادات سنويًا هامش الربح الصافي ROE هامش الربح الإجمالي
HCA $104.86B 16.5 7.1% 9.0% -159.1%
THC $17.28B 12.8 3.1% 11.1% 56.4%
EHC $10.61B 19.2 10.5% 9.5% 25.1%
ENSG $10.12B 29.8 18.7% 6.8% 16.9%
UHS 9.4 9.7% 8.6% 21.4%
PACS $6.01B 31.5 29.3% 3.6% 23.1%
CON $2.53B 15.1 13.9% 7.7% 49.8%
BKD $2.57B -9.6 2.2% -8.2% -313.2% 26.2%
ACHC $1.28B -1.2 5.0% -33.3% -43.9%
SGRY $2.00B -25.3 6.2% -2.4% -4.5%

الأساسيات الكاملة جميع المقاييس حسب السنة — قائمة الدخل، الميزانية العمومية، التدفق النقدي

قائمة الدخل 12
بيانات قائمة الدخل السنوية لـ HCA
المقياس اتجاه 2025202420232022202120202019201820172016
Revenue 10-point trend, +82.2% $75.60B $70.60B $64.97B $60.23B $58.75B $51.53B $51.34B $46.68B $43.61B $41.49B
SG&A Expense 10-point trend, +59.8% $548M $421M $353M $307M $337M $416M $370M $344M $340M $343M
Operating Expenses 10-point trend, +79.3% $65.77B $62.08B $57.26B $51.65B $48.92B $46.10B $46.09B $41.34B $39.23B $36.68B
Interest Expense 10-point trend, +31.7% $2.25B $2.06B $1.94B $1.74B $1.57B $1.58B $1.82B $1.75B $1.69B $1.71B
Pretax Income 10-point trend, +104.4% $9.83B $8.52B $7.71B $8.58B $9.83B $5.43B $5.24B $5.33B $4.38B $4.81B
Income Tax 10-point trend, +48.8% $2.05B $1.87B $1.61B $1.75B $2.11B $1.04B $1.10B $946M $1.64B $1.38B
Net Income 10-point trend, +134.7% $6.78B $5.76B $5.24B $5.64B $6.96B $3.75B $3.50B $3.79B $2.22B $2.89B
EPS (Basic) 10-point trend, +281.1% $28.70 $22.27 $19.25 $19.43 $21.52 $11.10 $10.27 $10.90 $6.12 $7.53
EPS (Diluted) 10-point trend, +288.1% $28.33 $22.00 $18.97 $19.15 $21.16 $10.93 $10.07 $10.66 $5.95 $7.30
Shares (Basic) 10-point trend, -38.4% 236,413,000 258,603,000 272,404,000 290,348,000 323,315,000 338,274,000 341,210,000 347,297,000 362,305,000 383,591,000
Shares (Diluted) 10-point trend, -39.5% 239,495,000 261,806,000 276,412,000 294,666,000 328,752,000 343,605,000 348,226,000 355,303,000 372,221,000 395,851,000
EBITDA 10-point trend, +79.2% $3.52B $3.31B $3.08B $2.97B $2.85B $2.72B $2.60B $2.28B $2.13B $1.97B
الميزانية العمومية 22
بيانات الميزانية العمومية السنوية لـ HCA
المقياس اتجاه 2025202420232022202120202019201820172016
Cash & Equivalents 10-point trend, +61.0% $1.04B $1.93B $935M $908M $1.45B $1.79B $621M $502M $732M $646M
Short-term Investments 5-point trend, +136.7% · · · · · $116M $147M $47M $54M $49M
Receivables 10-point trend, +86.5% $10.87B $10.75B $9.96B $8.89B $8.10B $7.05B $7.38B $6.79B $6.50B $5.83B
Inventory 10-point trend, +9.9% $1.65B $1.74B $2.02B $2.07B $1.99B $2.02B $1.85B $1.73B $1.57B $1.50B
Other Current Assets 10-point trend, +100.2% $2.22B $1.99B $2.01B $1.78B $2.01B $1.46B $1.35B $1.19B $1.17B $1.11B
Current Assets 10-point trend, +73.7% $15.78B $16.41B $14.93B $13.64B $13.54B $12.33B $11.20B $10.21B $9.98B $9.09B
PP&E (Net) 10-point trend, +90.4% $31.14B $29.41B $27.71B $25.57B $24.06B $23.20B $22.71B $19.76B $17.89B $16.35B
PP&E (Gross) 10-point trend, +78.9% $66.28B $62.51B $58.55B $54.76B $51.35B $49.32B $47.23B $42.97B $40.08B $37.05B
Accum. Depreciation 10-point trend, +69.7% $35.13B $33.10B $30.83B $29.18B $27.29B $26.12B $24.52B $23.21B $22.19B $20.70B
Other Non-current Assets 10-point trend, -76.3% $255M $230M $184M $298M $598M $546M $480M $690M $710M $1.07B
Total Assets 10-point trend, +79.9% $60.72B $59.51B $56.21B $52.44B $50.74B $47.49B $45.06B $39.21B $36.59B $33.76B
Accounts Payable 10-point trend, +101.0% $4.66B $4.28B $4.23B $4.24B $4.11B $3.54B $2.90B $2.58B $2.61B $2.32B
Current Liabilities 10-point trend, +180.3% $16.35B $15.18B $12.65B $9.90B $9.58B $8.70B $7.76B $7.57B $6.16B $5.83B
Capital Leases 7-point trend, +23.6% $1.85B $1.86B $1.90B $1.75B $1.75B $1.67B $1.50B · · ·
Total Liabilities 4-point trend, +15.8% · · · · · · $45.62B $42.12B $41.59B $39.39B
Long-term Debt 10-point trend, +41.1% $44.28B $43.03B $39.59B $38.08B $34.58B $31.00B $33.72B $32.82B $33.06B $31.38B
Total Debt 10-point trend, +32.6% $41.60B $43.03B $39.59B $38.08B $34.58B $31.00B $33.72B $32.82B $33.06B $31.38B
Retained Earnings 10-point trend, +17.9% $-5.72B $-2.12B $-1.35B $-2.28B $-532M $777M $-2.35B $-4.57B $-6.53B $-6.97B
AOCI 10-point trend, +9.8% $-305M $-387M $-425M $-490M $-404M $-502M $-460M $-381M $-278M $-338M
Stockholders' Equity 10-point trend, +17.5% $-6.03B $-2.50B $-1.77B $-2.77B $-933M $572M $-2.81B $-4.95B $-6.81B $-7.30B
Liabilities + Equity 10-point trend, +79.9% $60.72B $59.51B $56.21B $52.44B $50.74B $47.49B $45.06B $39.21B $36.59B $33.76B
Shares Outstanding 10-point trend, -39.4% 224,605,100 249,981,400 265,537,300 277,378,300 305,476,800 339,425,600 338,445,600 342,895,200 350,091,600 370,535,900
التدفق النقدي 17
بيانات التدفق النقدي السنوية لـ HCA
المقياس اتجاه 2025202420232022202120202019201820172016
D&A 10-point trend, +79.2% $3.52B $3.31B $3.08B $2.97B $2.85B $2.72B $2.60B $2.28B $2.13B $1.97B
Stock-based Comp 10-point trend, +59.8% $401M $360M $262M $341M $440M $362M $347M $268M $270M $251M
Amort. of Intangibles 6-point trend, -53.8% $12M $16M $20M $44M $25M $26M · · · ·
Other Non-cash 10-point trend, +172.2% $1.93B $1.08B $850M $-431M $-1.29B $2.40B $1.07B $461M $-3.53B $-2.67B
Operating Cash Flow 10-point trend, +123.5% $12.64B $10.51B $9.43B $8.52B $8.96B $9.23B $7.60B $6.76B $5.43B $5.65B
CapEx 10-point trend, +79.1% $4.94B $4.88B $4.74B $4.39B $3.58B $2.83B $4.16B $3.57B $3.02B $2.76B
Investing Cash Flow 10-point trend, -54.0% $-4.99B $-4.93B $-5.32B $-3.39B $-2.64B $-3.39B $-5.72B $-3.90B $-4.28B $-3.24B
Debt Issued 10-point trend, +56.9% $8.47B $7.50B $3.22B $6.00B $4.34B $2.70B $6.45B $2.00B $1.50B $5.40B
Net Debt Issued 10-point trend, +17.3% $1.08B $5.08B $2.31B $3.17B $475M $-737M $1.13B $296M $749M $925M
Stock Repurchased 10-point trend, +265.9% $10.07B $6.04B $3.81B $7.00B $8.21B $441M $1.03B $1.53B $2.05B $2.75B
Net Stock Activity 10-point trend, -265.9% $-10.07B $-6.04B $-3.81B $-7.00B $-8.21B $-441M $-1.03B $-1.53B $-2.05B $-2.75B
Dividends Paid 9-point trend, +679000000.00 $679M $690M $661M $653M $624M $153M $550M $487M $0 ·
Financing Cash Flow 10-point trend, -240.9% $-8.55B $-4.58B $-4.09B $-5.66B $-6.66B $-4.68B $-1.77B $-3.08B $-1.06B $-2.51B
Net Change in Cash 10-point trend, -840.0% $-893M $998M $27M $-543M $-342M $1.17B $119M $-230M $86M $-95M
Taxes Paid 10-point trend, +38.6% $1.74B $1.84B $1.39B $1.18B $2.18B $1.00B $849M $872M $1.21B $1.25B
Free Cash Flow 10-point trend, +165.9% $7.69B $5.64B $4.69B $4.13B $5.38B $6.40B $3.44B $3.19B $2.41B $2.89B
Levered FCF 10-point trend, +253.0% $5.91B $4.03B $3.16B $2.74B $4.15B $5.12B $2.00B $1.74B $1.35B $1.68B
الربحية 5
بيانات الربحية السنوية لـ HCA
المقياس اتجاه 2025202420232022202120202019201820172016
Net Margin 8-point trend, +10.6% 9.0% 8.2% 8.1% 9.4% 11.8% 7.3% 6.8% 8.1% · ·
Pretax Margin 8-point trend, +13.8% 13.0% 12.1% 11.9% 14.2% 16.7% 10.5% 10.2% 11.4% · ·
EBITDA Margin 8-point trend, -4.5% 4.7% 4.7% 4.7% 4.9% 4.9% 5.3% 5.1% 4.9% · ·
ROA 10-point trend, +29.8% 11.3% 10.0% 9.7% 10.9% 14.2% 8.1% 8.3% 10.0% 6.3% 8.7%
ROE 10-point trend, -310.3% -159.1% -269.6% -230.9% -305.0% -3853.7% -335.8% -90.4% -64.4% -31.4% -38.8%
السيولة والملاءة 4
بيانات السيولة والملاءة السنوية لـ HCA
المقياس اتجاه 2025202420232022202120202019201820172016
Current Ratio 10-point trend, -38.0% 1.0 1.1 1.2 1.4 1.4 1.4 1.4 1.3 1.6 1.6
Quick Ratio 10-point trend, -34.8% 0.7 0.8 0.9 1.0 1.0 1.0 1.1 1.0 1.2 1.1
Debt / Equity 10-point trend, -60.6% -6.9 -17.2 -22.3 -13.8 -37.1 54.2 -12.0 -6.6 -4.9 -4.3
LT Debt / Equity 10-point trend, -61.8% -6.9 -15.3 -21.0 -13.6 -36.8 53.8 -12.0 -6.5 -4.8 -4.3
الكفاءة 2
بيانات الكفاءة السنوية لـ HCA
المقياس اتجاه 2025202420232022202120202019201820172016
Asset Turnover 8-point trend, +2.1% 1.3 1.2 1.2 1.2 1.2 1.1 1.2 1.2 · ·
Receivables Turnover 8-point trend, -0.4% 7.0 6.8 6.9 7.1 7.8 7.1 7.2 7.0 · ·
لكل سهم 6
بيانات لكل سهم السنوية لـ HCA
المقياس اتجاه 2025202420232022202120202019201820172016
Book Value / Share 10-point trend, -36.2% $-26.83 $-10.00 $-6.68 $-9.98 $-3.05 $1.69 $-8.30 $-14.44 $-19.44 $-19.71
Revenue / Share 8-point trend, +140.3% $315.66 $269.68 $235.04 $204.41 $178.71 $149.98 $147.42 $131.37 · ·
Cash Flow / Share 10-point trend, +269.5% $52.76 $40.16 $34.12 $28.92 $27.25 $26.87 $21.83 $19.03 $14.58 $14.28
Cash / Share 10-point trend, +165.6% $4.63 $7.73 $3.52 $3.27 $4.75 $5.28 $1.83 $1.46 $2.09 $1.74
Dividend / Share 8-point trend, +105.7% $3 $3 $2 $2 $2 $0 $2 $1 · ·
EPS (TTM) 10-point trend, +288.1% $28.33 $22.00 $18.97 $19.15 $21.16 $10.93 $10.07 $10.66 $5.95 $7.30
معدلات النمو 10
بيانات معدلات النمو السنوية لـ HCA
المقياس اتجاه 2025202420232022202120202019201820172016
Revenue YoY 5-point trend, -49.5% 7.1% 8.7% 7.9% 2.5% 14.0% · · · · ·
Revenue CAGR 3Y 3-point trend, -2.0% 7.9% 6.3% 8.0% · · · · · · ·
Revenue CAGR 5Y 8.0% · · · · · · · · ·
EPS YoY 5-point trend, -69.3% 28.8% 16.0% -0.94% -9.5% 93.6% · · · · ·
EPS CAGR 3Y 3-point trend, -30.9% 13.9% 1.3% 20.2% · · · · · · ·
EPS CAGR 5Y 21.0% · · · · · · · · ·
Net Income YoY 5-point trend, -79.2% 17.8% 9.9% -7.1% -18.9% 85.3% · · · · ·
Net Income CAGR 3Y 3-point trend, -46.2% 6.3% -6.1% 11.8% · · · · · · ·
Net Income CAGR 5Y 12.6% · · · · · · · · ·
Dividend CAGR 5Y 34.7% · · · · · · · · ·
التقييم (آخر 12 شهرًا) 17
بيانات التقييم (آخر 12 شهرًا) السنوية لـ HCA
المقياس اتجاه 2025202420232022202120202019201820172016
Revenue TTM 10-point trend, +82.2% $75.60B $70.60B $64.97B $60.23B $58.75B $51.53B $51.34B $46.68B $43.61B $41.49B
Net Income TTM 10-point trend, +134.7% $6.78B $5.76B $5.24B $5.64B $6.96B $3.75B $3.50B $3.79B $2.22B $2.89B
Market Cap 10-point trend, +282.3% $104.86B $75.03B $71.88B $66.56B $78.48B $55.82B $50.03B $42.67B $30.75B $27.43B
Enterprise Value 10-point trend, +150.3% $145.42B $116.13B $110.53B $103.74B $111.61B $84.92B $82.98B $74.95B $63.02B $58.11B
P/E 10-point trend, +62.5% 16.5 13.6 14.3 12.5 12.1 15.0 14.7 11.7 14.8 10.1
P/S 10-point trend, +109.8% 1.4 1.1 1.1 1.1 1.3 1.1 1.0 0.9 0.7 0.7
P/B 10-point trend, -363.2% -17.4 -30.0 -40.5 -24.1 -84.1 97.6 -17.8 -8.6 -4.5 -3.8
P / Tangible Book · · · · · 97.6 · · · ·
P / Cash Flow 10-point trend, +71.0% 8.3 7.1 7.6 7.8 8.8 6.0 6.6 6.3 5.7 4.9
P / FCF 10-point trend, +43.8% 13.6 13.3 15.3 16.1 14.6 8.7 14.5 13.4 12.8 9.5
EV / EBITDA 10-point trend, +39.7% 41.3 35.1 35.9 34.9 39.1 31.2 32.0 32.9 29.6 29.6
EV / FCF 10-point trend, -5.9% 18.9 20.6 23.6 25.1 20.7 13.3 24.1 23.5 26.1 20.1
EV / Revenue 10-point trend, +37.4% 1.9 1.6 1.7 1.7 1.9 1.6 1.6 1.6 1.4 1.4
Dividend Yield 9-point trend, +0.01 0.65% 0.92% 0.92% 0.98% 0.80% 0.27% 1.1% 1.1% 0.00% ·
Earnings Yield 10-point trend, -38.4% 6.1% 7.3% 7.0% 8.0% 8.2% 6.7% 6.8% 8.6% 6.8% 9.9%
Payout Ratio 8-point trend, -22.2% 10.0% 12.0% 12.6% 11.6% 9.0% 4.1% 15.7% 12.9% · ·
Annual Payout 9-point trend, +679000000.00 $679M $690M $661M $653M $624M $153M $550M $487M $0 ·

القوائم المالية قائمة الدخل، الميزانية العمومية، التدفقات النقدية — سنويًا، آخر 5 سنوات

قائمة الدخل
2025-12-312024-12-312023-12-312022-12-312021-12-31
الإيرادات $75.60B$70.60B$64.97B$60.23B$58.75B
صافي الدخل $6.78B$5.76B$5.24B$5.64B$6.96B
EPS المخفف $28.33$22.00$18.97$19.15$21.16
الميزانية العمومية
2025-12-312024-12-312023-12-312022-12-312021-12-31
الدين / حقوق الملكية -6.9-17.2-22.3-13.8-37.1
النسبة الحالية 1.01.11.21.41.4
النسبة السريعة 0.70.80.91.01.0
التدفق النقدي
2025-12-312024-12-312023-12-312022-12-312021-12-31
التدفق النقدي الحر $7.69B$5.64B$4.69B$4.13B$5.38B

آخر الأخبار أحدث العناوين التي تذكر هذه الشركة

مقاييسي قائمة المراقبة الشخصية الخاصة بك — صفوف مختارة من الأساسيات الكاملة

📊

اختر المقاييس التي تهمك — انقر فوق علامة ➕ بجوار أي صف في الأساسيات الكاملة أعلاه.

يتم حفظ اختيارك ويتبعك عبر جميع الأسهم.

الملاك المؤسسيون (13F) 1486 مقدمي إقرار · $39.4B إجمالي · حتى تاريخ 30 يونيو، 2026

المؤسسات التي تبلغ عن حيازتها لهذا السهم في نموذج SEC 13F ربع السنوي الخاص بها. المراكز الطويلة فقط؛ قد يظهر مقدم واحد مرتين لأرجل خيارات منفصلة. الأرجل الكبيرة المتعاكسة من خيارات البيع/الشراء تعكس عادةً صناعة السوق أو المخزون المتحوط، وليس القناعة الاتجاهية.

النشاط المؤسسي — Q2 2026 مقابل الربع السابق
مراكز جديدة المراكز الخارجة زيادة انخفض صافي التغير في الأسهم
128 (-51 مقابل الربع السابق) 174 (+70 مقابل الربع السابق) 450 (-30 مقابل الربع السابق) 555 (-4 مقابل الربع السابق) +16.3M

مقارنة بـ Q1 2026. المواعيد النهائية لتقديم إقرارات نموذج 13F لهيئة الأوراق المالية والبورصات (SEC) هي في غضون 45 يومًا من نهاية الربع بالإضافة إلى فترة سماح قصيرة للمقدمين المتأخرين — يتم تخطي الأرباع التي لا تزال ضمن هذه النافذة لصالح أحدث زوج تم الإبلاغ عنه بالكامل.

مؤسسة القيمة الأسهم % من 13F المتتبعة النوع
VANGUARD GROUP INC $6118113464 13104814 15,52% الأسهم
VANGUARD CAPITAL MANAGEMENT LLC $3954150533 10141708 10,03% الأسهم
Sanders Capital, LLC $3442060818 8828287 8,73% الأسهم
STATE STREET CORP $2912102056 7469035 7,39% الأسهم
WELLINGTON MANAGEMENT GROUP LLP $1750298867 4489212 4,44% الأسهم
GEODE CAPITAL MANAGEMENT, LLC $1225259672 3159159 3,11% الأسهم
VANGUARD PORTFOLIO MANAGEMENT LLC $1057704509 2712828 2,68% الأسهم
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP $861456107 2209485 2,19% الأسهم
NORGES BANK $836457140 2145367 2,12% الأسهم
Capital World Investors $770864224 1977121 1,96% الأسهم
Capital International Investors $747403041 1916947 1,90% الأسهم
Crake Asset Management LLP $449072183 1151792 1,14% الأسهم
Metropolis Capital Ltd $430915307 910564 1,09% الأسهم
Darsana Capital Partners LP $428879000 1100000 1,09% الأسهم
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $414533777 1063207 1,05% الأسهم
Life Cycle Investment Partners Ltd $355737196 912404 0,90% الأسهم
VANGUARD FIDUCIARY TRUST CO $339685814 871235 0,86% الأسهم
FMR LLC $325199295 834080 0,83% الأسهم
BARCLAYS PLC $299888573 769162 0,76% الأسهم
LYRICAL ASSET MANAGEMENT LP $255015742 654071 0,65% الأسهم
BlackRock, Inc. $240062291 615718 0,61% الأسهم
ROYAL LONDON ASSET MANAGEMENT LTD $235649908 604401 0,60% الأسهم
National Pension Service $230650346 591578 0,59% الأسهم
NORDEA INVESTMENT MANAGEMENT AB $230189125 594466 0,58% الأسهم
GOLDMAN SACHS GROUP INC $209775669 538038 0,53% الأسهم
Gobi Capital LLC $195742325 502045 0,50% الأسهم
Cryder Capital Partners LLP $194561738 499017 0,49% الأسهم
Swiss National Bank $172097446 441400 0,44% الأسهم
AustralianSuper Pty Ltd $159635782 409438 0,41% الأسهم
Consulta Ltd $155956000 400000 0,40% الأسهم
LEE DANNER & BASS INC $152150679 390240 0,39% الأسهم
SUSQUEHANNA INTERNATIONAL GROUP, LLP $151472265 388500 0,38% عقد خيار الشراء
Mitsubishi UFJ Asset Management Co., Ltd. $147943761 379450 0,38% الأسهم
DIMENSIONAL FUND ADVISORS LP $139697405 358300 0,35% الأسهم
Vanguard Global Advisers, LLC $136962509 351285 0,35% الأسهم
VIRGINIA RETIREMENT SYSTEMS ET Al $134838505 288820 0,34% الأسهم
ALLIANCEBERNSTEIN L.P. $134459788 284126 0,34% الأسهم
Sumitomo Mitsui Trust Group, Inc. $132794974 340596 0,34% الأسهم
TD Asset Management Inc $131847152 338165 0,33% الأسهم
Legal & General Group Plc $127805162 327798 0,32% الأسهم
California Public Employees Retirement System $124133958 318382 0,31% الأسهم
LAZARD ASSET MANAGEMENT LLC $120619879 309369 0,31% الأسهم
JANE STREET GROUP, LLC $119540274 306600 0,30% عقد خيار الشراء
VANGUARD ASSET MANAGEMENT, Ltd $116069863 297699 0,29% الأسهم
CAPTRUST FINANCIAL ADVISORS $114741071 294291 0,29% الأسهم
ANTIPODES PARTNERS Ltd $113045096 289941 0,29% الأسهم
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM $109718328 231845 0,28% الأسهم
CITADEL ADVISORS LLC $105660190 271000 0,27% عقد خيار الشراء
RHUMBLINE ADVISERS $97580413 250277 0,25% الأسهم
O'SHAUGHNESSY ASSET MANAGEMENT, LLC $97026076 248855 0,25% الأسهم
MACKENZIE FINANCIAL CORP $93597383 240061 0,24% الأسهم
BloombergSen Inc. $93160317 238940 0,24% الأسهم
SUSQUEHANNA INTERNATIONAL GROUP, LLP $92247974 236600 0,23% عقد خيار البيع
Brandywine Global Investment Management, LLC $89380814 191451 0,23% الأسهم
BANK OF AMERICA CORP /DE/ $89069981 228449 0,23% الأسهم
NEUBERGER BERMAN GROUP LLC $85926216 220386 0,22% الأسهم
MILFORD FUNDS LTD $82165029 210739 0,21% الأسهم
Bridgewater Associates, LP $79227208 203204 0,20% الأسهم
Prana Capital Management, LP $75552494 193779 0,19% الأسهم
DANSKE BANK A/S $73238497 187844 0,19% الأسهم
FRANKLIN RESOURCES INC $70965828 182015 0,18% الأسهم
VOLORIDGE INVESTMENT MANAGEMENT, LLC $70445715 180681 0,18% الأسهم
Quantinno Capital Management LP $70407055 180581 0,18% الأسهم
ARGENT CAPITAL MANAGEMENT LLC $69149681 177357 0,18% الأسهم
Retirement Systems of Alabama $68081812 174618 0,17% الأسهم
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND $66167842 169709 0,17% الأسهم
BNP PARIBAS FINANCIAL MARKETS $64793090 166183 0,16% الأسهم
BNP PARIBAS ASSET MANAGEMENT Holding S.A. $64665206 165855 0,16% الأسهم
HSBC HOLDINGS PLC $64431534 165332 0,16% الأسهم
AVIVA PLC $64264789 164828 0,16% الأسهم
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC $64194533 135649 0,16% الأسهم
SEB Asset Management AB $63257255 162244 0,16% الأسهم
TODD ASSET MANAGEMENT LLC $62567208 160474 0,16% الأسهم
Swedbank AB $62528998 160376 0,16% الأسهم
W1M Investment Management Ltd $61247490 143647 0,16% الأسهم
HARRIS ASSOCIATES L P $60080879 154097 0,15% الأسهم
Ensign Peak Advisors, Inc $58372381 149715 0,15% الأسهم
NEW YORK STATE COMMON RETIREMENT FUND $57747778 148113 0,15% الأسهم
CITADEL ADVISORS LLC $57235852 146800 0,15% عقد خيار البيع
Universal- Beteiligungs- und Servicegesellschaft mbH $57160993 146800 0,15% الأسهم
LOS ANGELES CAPITAL MANAGEMENT LLC $56512217 144944 0,14% الأسهم
Pictet Asset Management Holding SA $52147803 133739 0,13% الأسهم
VICTORY CAPITAL MANAGEMENT INC $50752761 130172 0,13% الأسهم
Pentwater Capital Management LP $50685700 130000 0,13% الأسهم
D. E. Shaw & Co., Inc. $50554307 129663 0,13% الأسهم
APG Asset Management N.V. $50368550 147699 0,13% الأسهم
AMF Tjanstepension AB $50355853 129154 0,13% الأسهم
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM $50349225 129137 0,13% الأسهم
EQUITABLE TRUST CO $49147974 126056 0,12% الأسهم
ENVESTNET ASSET MANAGEMENT INC $48919124 125469 0,12% الأسهم
CANADA PENSION PLAN INVESTMENT BOARD $48197812 123619 0,12% الأسهم
AMERICAN CENTURY COMPANIES INC $47460140 121727 0,12% الأسهم
OpenArc Corporate Advisory, LLC $47210610 121087 0,12% الأسهم
L1 Capital International Pty Ltd $46121648 118294 0,12% الأسهم
FIRST TRUST ADVISORS LP $44251579 113498 0,11% الأسهم
PFA Pension, Forsikringsaktieselskab $44046098 112971 0,11% الأسهم
United Super Pty Ltd in its capacity as Trustee for the Construction & Building Unions Superannuation Fund $43830264 112417 0,11% الأسهم
EP Wealth Advisors, LLC $43287826 111026 0,11% الأسهم
WOLVERINE TRADING, LLC $42597104 101200 0,11% عقد خيار الشراء
MERCER GLOBAL ADVISORS INC /ADV $42302070 108497 0,11% الأسهم

المطلعون على الشركة 91 من المطلعين · مسؤولون 54 · مديرون 31

مطلع الدور آخر نشاط الأسهم المملوكة مشتريات 12 شهرًا مبيعات 12 شهرًا صافي 12 شهرًا
Samuel N Hazen CEO 10 فبراير، 2026 F 64842 0 7 $-21483290
O'Boyle Michael P President & CEO - Parallon 26 فبراير، 2013 A 21429 0 0 $0
Mike A Marks EVP and CFO 7 مايو، 2026 G 46576 0 0 $0
Bill B Rutherford CFO and EVP 16 فبراير، 2024 F 22251 0 0 $0
Russell K Harms CFO - Central Group 17 نوفمبر، 2006 D 0 0 0 $0
Robert Samuel Hankins JR CFO-Outpatient Services Group 17 نوفمبر، 2006 D 0 0 0 $0
Richard J Shallcross CFO - Western Group 17 نوفمبر، 2006 D 0 0 0 $0
Jeffrey T Crudele CFO-Eastern Division 1 يوليو، 2005 F 13865 0 0 $0
Erol R Akdamar Group President 12 نوفمبر، 2024 M 6843 0 0 $0
Timothy M Mcmanus Group President 31 يوليو، 2024 M 27008 0 0 $0
Richard A Hammett Group President 16 فبراير، 2024 F 17936 0 0 $0
Charles J Hall Group President 11 نوفمبر، 2022 M 202443 0 0 $0
Bruce A Moore JR Group President - Service Line 11 نوفمبر، 2022 S 30807 0 0 $0
Paul W Rutledge Group President 31 ديسمبر، 2012 A 335657 0 0 $0
Beverly B Wallace President - Parallon 2 نوفمبر، 2011 M 144714 0 0 $0
Charles Robert Evans President - Eastern Group 26 يوليو، 2006 A 62173 0 0 $0
Marilyn B Tavenner President-Outpatient Svcs Grp 27 أكتوبر، 2005 A 26154 0 0 $0
Greg Roth President-Ambulatory Surgery 31 أكتوبر، 2004 D 9029 0 0 $0
Jay Grinney President-Eastern Group 7 مايو، 2004 D 24177 0 0 $0
Jon M Foster EVP and COO 10 فبراير، 2026 F 23062 0 0 $0
Michael R Mcalevey EVP & Chief Legal & Admin Off. 13 فبراير، 2026 M 8853 0 2 $-2747520
Jennifer Berres SVP & Chief Human Res. Officer 11 فبراير، 2026 S 11993 0 2 $-4126932
Christopher F. Wyatt SVP & Controller 11 فبراير، 2026 S 44379 0 1 $-2020000
Erica Rossitto SVP & Chief Nurse Executive 10 فبراير، 2026 F 10407 0 0 $0
Michael S. Cuffe EVP and Chief Clinical Officer 10 فبراير، 2026 F 32080 0 1 $-747135
Sammie S Mosier SVP & Chief Nurse Executive 13 فبراير، 2025 F 11113 0 0 $0
Kathleen M Whalen SVP & Chief Ethics Officer 14 نوفمبر، 2024 S 9454 0 0 $0
Phillip G Billington SVP-Internal Audit Services 12 نوفمبر، 2024 M 52702 0 0 $0
Joseph A Sowell III SVP; Chief Development Officer 5 أغسطس، 2024 G 18526 0 0 $0
Deborah M Reiner SVP - Mktg. & Communications 29 يوليو، 2024 S 3510 0 0 $0
Kathryn A. Torres SVP-Payer Contracting & Align. 25 يوليو، 2024 S 17755 0 0 $0
Jeffrey E. Cohen SVP-Government Relations 9 مايو، 2024 S 5185 0 0 $0
Chad J Wasserman SVP and CIO 18 مارس، 2024 M 1576 0 0 $0
Martin P. Paslick SVP and CIO 12 إبريل، 2023 M 24643 0 0 $0
Jane D. Englebright SVP and Chief Nursing Officer 9 نوفمبر، 2021 S 0 0 0 $0
Robert A Waterman SVP & General Counsel 5 مايو، 2021 S 50062 0 0 $0
William J Morrow SVP - Finance and Treasurer 18 فبراير، 2021 F 5578 0 0 $0
Sandra L. Morgan SVP-Provider Relations 18 فبراير، 2021 F 10122 0 0 $0
Victor L Campbell SVP-Government Affairs 1 مايو، 2019 A 194145 0 0 $0
John M Steele SVP & Chief Human Res. Officer 25 فبراير، 2019 M 84157 0 0 $0
Milton R Johnson Chairman 25 فبراير، 2019 M 881823 0 0 $0
Ravi S. Chari SVP-Clinical Excellence 25 فبراير، 2018 M 7003 0 0 $0
Alan R Yuspeh SVP & Chief Ethics Officer 25 فبراير، 2018 M 35546 0 0 $0
Joseph N Steakley SVP-Internal Audit Services 25 فبراير، 2018 M 65199 0 0 $0
Jana Joustra Davis SVP - Mktg. & Corp. Affairs 23 مايو، 2017 M 26378 0 0 $0
David Gwin Anderson SVP - Finance 7 نوفمبر، 2016 M 110167 0 0 $0
Donald W Stinnett SVP & Controller 25 فبراير، 2016 A 51965 0 0 $0
Noel B Williams SVP and CIO 16 مايو، 2012 M 299030 0 0 $0
Jack O Bovender JR Chairman 6 أكتوبر، 2009 A 188340 0 0 $0
Carl V George SVP - Development 27 فبراير، 2009 M 13092 0 0 $0

المطلعون من إيداعات SEC Form 3/4/5؛ صافي = سوق مفتوح فقط

الناشطون والمالكون بنسبة 5%+ 4 حيازات

المستثمرون الذين قدموا الجدول الزمني 13D لدى هيئة الأوراق المالية والبورصات — ملكية مستفيدة تزيد عن 5% مع نية التأثير على المُصدر (حصص الناشطين، حملات مجلس الإدارة، الاندماج والاستحواذ). يعرض كل صف أحدث حالة معروفة لمركز مقدم الطلب هذا.

مقدم مقدم حصة الحالة الغرض إيداع
Frisco Holding II, Hercules Holding II, Thomas F. Frist, Jr., Thomas F. Frist III, William R. Frist, Patricia F. Elcan 10 فبراير، 2026 31,60% إيداع أولي SEC
22 نوفمبر، 2006 إيداع أولي SEC
Merrill Lynch Bank USA 11 سبتمبر، 2006 إيداع أولي SEC
Frisco, Inc., Frisco Partners, Thomas F. Frist, Jr., Patricia Champion Frist, Patricia Frist Elcan, William Robert Frist, Thomas F. Frist III, Merrill Lynch Professional Clearing Corp., Merrill Lynch, Pierce, Fenner & Smith Incorporated, Merrill Lynch Financial Markets, Inc., Merrill Lynch International, Merrill Lynch & Co., Inc., Merrill Lynch Trust Company, FSB, Citigroup Inc.*, Bank of America Corporation, NB Holdings Corporation, NationsBanc Montgomery Holdings Corporation, Banc of America Securities LLC 4 أغسطس، 2006 إيداع أولي SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

ملكية صناديق المؤشرات المتداولة محتفظ بها بواسطة 207 صناديق مؤشرات متداولة

الوزن يعكس فقط ممتلكات الأسهم المباشرة (N-PORT)؛ قد تحتفظ الصناديق المضاعفة أو القائمة على المشتقات بتعرض إضافي للمقايضة غير معروض.

صندوق الوزن الوحدات حتى تاريخ المصدر
IHF · iShares Trust 4,67% 141320 SH 8 أغسطس، 2026 يومي
BUL · Pacer Funds Trust 3,91% 11437 NS 30 إبريل، 2026 N-PORT
YALL · Tidal Trust I 3,61% 9261 NS 31 مايو، 2026 N-PORT
BWTG · ETF Opportunities Trust 3,02% 1646 NS 31 مايو، 2026 N-PORT
PKW · Invesco Exchange-Traded Fund Trust 2,32% 99335 SH 8 أغسطس، 2026 يومي
ABIG · EA Series Trust 2,00% 2938 NS 29 مايو، 2026 N-PORT
FXH · First Trust Exchange-Traded AlphaDE… 1,99% 39985 NS 30 إبريل، 2026 N-PORT
RSPH · Invesco Exchange-Traded Fund Trust 1,67% 31685 SH 8 أغسطس، 2026 يومي
COWZ · Pacer Funds Trust 1,64% 688264 NS 30 إبريل، 2026 N-PORT
QQWZ · Pacer Funds Trust 1,64% 1762 NS 30 إبريل، 2026 N-PORT
FEGE · RBB Fund Trust 1,46% 74706 NS 31 مايو، 2026 N-PORT
PWV · Invesco Exchange-Traded Fund Trust 1,39% 60385 SH 8 أغسطس، 2026 يومي
RPG · Invesco Exchange-Traded Fund Trust 1,30% 63448 SH 8 أغسطس، 2026 يومي
TMFE · RBB Fund, Inc. 1,29% 2892 NS 31 مايو، 2026 N-PORT
AMID · EA Series Trust 1,23% 3402 NS 29 مايو، 2026 N-PORT
FCPI · FIDELITY COVINGTON TRUST 1,15% 7180 NS 30 إبريل، 2026 N-PORT
FMAG · FIDELITY COVINGTON TRUST 1,12% 6544 NS 30 إبريل، 2026 N-PORT
FHLC · FIDELITY COVINGTON TRUST 1,12% 73639 NS 30 إبريل، 2026 N-PORT
SRHQ · Elevation Series Trust 1,10% 4883 NS 30 إبريل، 2026 N-PORT
IYH · iShares Trust 0,99% 89420 SH 8 أغسطس، 2026 يومي
NEAR · iShares U.S. ETF Trust 0,99% 48109000 SH 8 أغسطس، 2026 يومي
CURE · Direxion Shares ETF Trust 0,98% 3122 NS 30 إبريل، 2026 N-PORT
VHT · VANGUARD WORLD FUND 0,90% 470451 SH 8 أغسطس، 2026 يومي
NFRA · FlexShares Trust 0,88% 62176 NS 30 إبريل، 2026 N-PORT
REVS · Columbia ETF Trust I 0,87% 5693 NS 30 إبريل، 2026 N-PORT
RXL · ProShares Trust 0,86% 1632 NS 31 مايو، 2026 N-PORT
DIVB · iShares Trust 0,85% 36806 SH 8 أغسطس، 2026 يومي
BSCT · Invesco Exchange-Traded Self-Indexe… 0,82% 24078000 8 أغسطس، 2026 يومي
LSEQ · Harbor ETF Trust 0,81% 285 NS 30 إبريل، 2026 N-PORT
IXJ · iShares Trust 0,80% 81465 SH 8 أغسطس، 2026 يومي
BSCS · Invesco Exchange-Traded Self-Indexe… 0,76% 26493000 8 أغسطس، 2026 يومي
SPVM · Invesco Exchange-Traded Fund Trust 0,74% 2335 SH 8 أغسطس، 2026 يومي
FTC · First Trust Exchange-Traded AlphaDE… 0,73% 21329 NS 30 إبريل، 2026 N-PORT
RFFC · ALPS ETF Trust 0,68% 533 NS 31 مايو، 2026 N-PORT
QUVU · Hartford Funds Exchange-Traded Trust 0,68% 2698 NS 30 إبريل، 2026 N-PORT
VFMF · VANGUARD WELLINGTON FUND 0,67% 12075 SH 8 أغسطس، 2026 يومي
VCEB · VANGUARD WORLD FUND 0,62% 8146000 PA 8 أغسطس، 2026 يومي
FDMO · FIDELITY COVINGTON TRUST 0,61% 11771 NS 30 إبريل، 2026 N-PORT
RECS · Columbia ETF Trust I 0,58% 72768 NS 30 إبريل، 2026 N-PORT
AFLG · First Trust Exchange-Traded Fund VI… 0,56% 9664 NS 31 مايو، 2026 N-PORT
VFVA · VANGUARD WELLINGTON FUND 0,55% 11876 SH 8 أغسطس، 2026 يومي
VLLU · Harbor ETF Trust 0,54% 54 NS 30 إبريل، 2026 N-PORT
LSVD · ADVISORS' INNER CIRCLE FUND 0,53% 7404 NS 30 إبريل، 2026 N-PORT
WLDR · Two Roads Shared Trust 0,51% 844 NS 30 إبريل، 2026 N-PORT
VALQ · AMERICAN CENTURY ETF TRUST 0,50% 4620 NS 31 مايو، 2026 N-PORT
AKAF · ETF Series Solutions 0,50% 39 NS 31 مايو، 2026 N-PORT
BSCR · Invesco Exchange-Traded Self-Indexe… 0,50% 22679000 8 أغسطس، 2026 يومي
ROUS · Lattice Strategies Trust 0,47% 6388 NS 30 إبريل، 2026 N-PORT
VCLT · VANGUARD SCOTTSDALE FUNDS 0,46% 54218000 PA 8 أغسطس، 2026 يومي
CGGR · Capital Group Growth ETF 0,45% 290273 NS 31 مايو، 2026 N-PORT